Early Use of High-efficacy DMTs Favor Lesser Disability Over Time

Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how early use of high efficacy DMTs favor lesser disability over time.

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Jessie Ace, Disabled to Enabled, “Focusing on What I Can Do Rather Than What I Can’t”.

=====================================

Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.

https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud

=====================================

Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/

=====================================

To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/